CareTrust REIT, Inc. (CTRE) — Fair Value Analysis

Base-case fair value (P50): $32.40 · Current price: $41.33 · Verdict: Overvalued

The Verdict on CTRE

CARETRUST REIT INC (CTRE) currently appears deeply overvalued. Based on sophisticated Monte Carlo simulations, the company's median fair value (P50) is estimated at $32.40. This stands in stark contrast to its current trading price of $41.33, representing a significant -21.6% gap. This substantial divergence strongly supports the "Deeply Overvalued" verdict, suggesting that CTRE's market price has outpaced its fundamental valuation derived from probabilistic modeling of future cash flows and market scenarios.

How CTRE stacks up against peers

CTRE's quality tier, which assesses its operational and financial health relative to its sector, is currently unrated. This unrated status means a direct comparison of its fundamental strength against peers is not yet established within our framework. However, the current price of $41.33 trading considerably above the calculated median fair value of $32.40 indicates that its valuation concerns are significant, irrespective of a comparative quality rating. Investors should note this lack of a clear qualitative tier in conjunction with the quantitative overvaluation signal.

What this means for investors

The Monte Carlo simulations consistently point to a substantial overvaluation for CTRE. With a current price of $41.33 versus a median fair value (P50) of $32.40, the -21.6% discrepancy implies considerable downside risk from a valuation perspective. The "Deeply Overvalued" verdict signals a potential re-rating to align with its intrinsic value. Understanding the full probability distribution, including bear and bull case scenarios, is crucial for informed decision-making. Sign up for a free FairCurve account to see the full bear/bull distribution and track CTRE's fair value as new fundamentals are released.